Use of Onyx (a patented ethylene-vinyl alcohol copolymer formulation) embolisation of cerebral arteriovenous malformations in Hong Kong: Initial experience
Publication in refereed journal


全文

其它資訊
摘要Objective: To review the experience with Onyx embolisation of cerebral arteriovenous malformation. Design: Prospective study. Setting: A regional neurosurgical centre in Hong Kong. Patients Data of patients with cerebral arteriovenous malformation who underwent Onyx embolisation over a 14-month period were prospectively collected. Results: Eleven sessions of Onyx embolisation were performed in nine patients with cerebral arteriovenous malformations, seven of which had ruptured. Total occlusion was achieved in three (33%) of the patients, and subtotal occlusion (over 80% occlusion) in three out of four with Spetzler-Martin grade-III/IV malformations. One patient developed mild permanent neurological deficit. Conclusion: Onyx embolisation of cerebral arteriovenous malformations is feasible in Hong Kong. Careful patient and target selection are important.
著者Wong G.K.C., Yu S.C.H., Zhu X.L., Kam M.K.M., Poon W.S.
期刊名稱Hong Kong Medical Journal
出版年份2009
月份10
日期1
卷號15
期次5
出版社Hong Kong Academy of Medicine Press
出版地Hong Kong
頁次359 - 364
國際標準期刊號1024-2708
語言英式英語
關鍵詞Embolization, therapeutic, Intracranial arteriovenous malformations, Polyvinyls, Treatment outcome

上次更新時間 2020-30-11 於 00:26